市場調査レポート

商品コード

1790177

細胞・遺伝子治療開発製造受託機関の市場規模、シェア、動向分析レポート：タイプ別、サービス別、適応症別、モダリティ別、地域別、セグメント予測、2025～2033年

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type, By Service, By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033

出版日: 2025年07月14日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 884,943円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,033,673円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,331,133円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.73円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細胞・遺伝子治療開発製造受託機関市場のサマリー

世界の細胞・遺伝子治療開発製造受託機関の市場規模は2024年に48億4,000万米ドルと推計され、2033年には1,126万米ドルに達すると予測され、2025～2033年までのCAGRは9.89%で成長します。成長の背景には、CGTにおける臨床試験量の増加、バイオテクノロジー企業によるアウトソーシングの増加、規制の複雑化、グローバル展開などがあります。

細胞・遺伝子治療開発製造受託機関業界の成長は、特に腫瘍学、血液学、希少遺伝性疾患における臨床パイプラインの急速な拡大によって後押しされています。スポンサーは、CGT試験の高い複雑性、規制の精査、コスト強度のため、CROをますます利用するようになっています。これらの治療法では、専門的なロジスティクス、個別化された製造調整、高度なデータ処理能力が要求されるため、中小規模のバイオテクノロジー企業の多くは外部委託を好んでいます。さらに、ATMPの治験薬（IND）申請が世界的に増加していることから、薬事サポート、試験デザイン、長期安全性モニタリングサービスに対する需要が高まっています。

CRISPRのような遺伝子編集プラットフォームやウイルス・非ウイルス送達技術の開発は、CGT開発に変革をもたらし、専門家主導の前臨床・臨床研究サポートの必要性を高めています。探索、前臨床バリデーション、ベクター解析、GMPコンプライアンスにまたがる統合ソリューションを提供するCROは競争力を増しています。さらに、資金調達の増加、戦略的パートナーシップ、業界の統合により、CROエコシステムのイノベーションの急増に伴う拡張能力が強化されています。このエコシステムの変化により、専門CROは、CGTの承認と国際共同治験の実施を加速する上で不可欠なパートナーとして位置付けられています。

セグメントダッシュボード
変動分析：サービス別
市場規模・動向分析：サービス別、2021～2033年
プロジェクト・臨床試験管理
規制戦略
データ管理・メディカルライティング
臨床モニタリング
品質管理/GMP準拠
生物統計学・安全性モニタリング
患者・施設の募集
技術移転
その他

第6章細胞・遺伝子治療開発製造受託機関市場：適応症別、推定・動向分析

セグメントダッシュボード
変動分析：適応症別
市場規模・動向分析：適応症別、2021～2033年
腫瘍学
中枢神経系疾患
感染症
免疫疾患
心血管疾患
呼吸器疾患
糖尿病
眼科
疼痛管理
その他

第7章細胞・遺伝子治療開発製造受託機関市場：モダリティ別、推定・動向分析

セグメントダッシュボード
変動分析：モダリティ別
市場規模・動向分析：モダリティ別、2021～2033年
細胞療法
遺伝子治療
遺伝子組み換え細胞療法

第8章細胞・遺伝子治療開発製造受託機関市場：地域別、推定・動向分析

市場ダッシュボード
世界市場のスナップショット
市場規模、予測・動向分析：地域別、2021～2033年
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

企業分類
細胞・遺伝子治療開発製造受託機関の市場シェア分析（2024年）
企業プロファイル
- Altasciences
- Allucent
- Labcorp
- Linical
- Medpace
- Thermo Fisher Scientific Inc.
- Precision Medicine Group, LLC.
- QPS Holdings
- Syneos Health
- ICON plc

図表

List of Tables

Table 1 List of abbreviation
Table 2 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 3 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 4 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 5 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 6 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 7 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
Table 8 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 9 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 10 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 11 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 12 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 13 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 14 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 15 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 16 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 17 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 18 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 19 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 20 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 21 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 22 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 23 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 24 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 25 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
Table 26 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 27 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 28 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 29 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 30 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 31 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 32 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 33 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 34 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 35 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 36 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 37 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 38 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 39 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 40 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 41 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 42 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 43 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 44 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 45 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 46 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 47 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 48 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 49 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 50 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 51 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 52 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 53 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 54 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 55 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Phase, 2021 - 2033 (USD Million)
Table 56 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 57 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 58 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 59 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 60 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 61 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
Table 63 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 64 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 65 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 66 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 67 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 68 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 69 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 70 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 71 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 72 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 73 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 74 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 75 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 76 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 77 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 78 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 79 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 80 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 81 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 82 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 83 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 84 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 85 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 86 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 87 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 88 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 89 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 90 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 91 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 92 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
Table 93 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 94 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 95 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 96 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 97 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 98 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 99 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 100 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 101 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 102 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 103 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 104 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 105 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
Table 106 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 107 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 108 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 109 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 110 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 111 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 112 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 114 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 115 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 116 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 117 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
Table 118 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
Table 119 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
Table 120 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
Table 121 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Cell & Gene Therapy Contract Research Organizations market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook, 2024 (USD Million)
Fig. 17 Ancillary market outlook, 2024 (USD Million)
Fig. 18 Cell & Gene Therapy Contract Research Organizations Market Dynamics
Fig. 19 Total R&D drug pipeline size, 2021 - 2024
Fig. 20 Total drug pipeline by development phase, 2024
Fig. 21 Porter's five forces analysis
Fig. 22 PESTEL analysis
Fig. 23 Cell & Gene Therapy Contract Research Organizations market Type outlook: Segment dashboard
Fig. 24 Cell & Gene Therapy Contract Research Organizations market, by Type segment: Market share, 2025 & 2033
Fig. 25 Drug Discovery market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Target Validation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Lead Identification market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Lead Optimization market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Cell & Gene Therapy Contract Research Organizations market Phase outlook: Segment dashboard
Fig. 32 Cell & Gene Therapy Contract Research Organizations market, by Phase segment: Market share, 2024 & 2033
Fig. 33 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Cell & Gene Therapy Contract Research Organizations market Service outlook: Segment dashboard
Fig. 38 Cell & Gene Therapy Contract Research Organizations market, by Service segment: Market share, 2024 & 2033
Fig. 39 Project & Clinical Trial Management market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Regulatory Strategy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Data Management & Medical Writing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Clinical Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Quality Management / GMP Compliance market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Biostatistics & Safety Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Patient & Site Recruitment market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Technology Transfer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Cell & Gene Therapy Contract Research Organizations market Indication outlook: Segment dashboard
Fig. 49 Cell & Gene Therapy Contract Research Organizations market, by Indication segment: Market share, 2024 & 2033
Fig. 50 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 CNS Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Immunological Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Cardiovascular Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Respiratory Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Pain Management market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Cell & Gene Therapy Contract Research Organizations market Modality outlook: Segment dashboard
Fig. 61 Cell & Gene Therapy Contract Research Organizations market, by Modality segment: Market share, 2024 & 2033
Fig. 62 Cell-Based Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Gene Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Gene-Modified Cell Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Regional market: Key takeaways
Fig. 66 Regional marketplace: Key takeaways
Fig. 67 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 104 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 109 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 114 Key country dynamics
Fig. 115 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 116 Key country dynamics
Fig. 117 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 118 Market participant categorization
Fig. 119 Heat map analysis

Product Code: GVR-4-68040-672-7

Cell & Gene Therapy Contract Research Organizations Market Summary

The global cell & gene therapy contract research organizations market size was estimated at USD 4.84 billion in 2024 and is projected to reach USD 11.26 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The growth is due to the rising clinical trial volume in CGT, increased outsourcing by biotech firms, regulatory complexity, and global expansion, among others.

The growth of the cell & gene therapy contract research organizations industry is fueled by the rapid expansion of clinical pipelines, especially in oncology, hematologic, and rare genetic disorders. Sponsors are increasingly turning to CROs due to the high complexity, regulatory scrutiny, and cost intensity of CGT trials. These therapies demand specialized logistics, personalized manufacturing coordination, and sophisticated data handling capabilities that most small to mid-sized biotech firms prefer to outsource. Moreover, the global increase in Investigational New Drug (IND) applications for ATMPs has heightened demand for regulatory support, trial design, and long-term safety monitoring services.

Advancements in gene-editing platforms such as CRISPR and viral and non-viral delivery technologies are transforming CGT development, thereby intensifying the need for expert-led preclinical and clinical research support. CROs offering integrated solutions across discovery, preclinical validation, vector analytics, and GMP compliance are gaining a competitive edge. Additionally, increased funding, strategic partnerships, and industry consolidation have enhanced the CRO ecosystem's capacity to scale with the innovation surge. This ecosystem shift has positioned specialized CROs as essential partners in accelerating CGT approvals and global trial execution.

Global Cell & Gene Therapy Contract Research Organizations Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell & gene therapy contract research organizations market report based on type, service, indication, modality, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
Preclinical
Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
Service Outlook (Revenue, USD Million, 2021 - 2033)
Project & Clinical Trial Management
Regulatory Strategy
Data Management & Medical Writing
Clinical Monitoring
Quality Management / GMP Compliance
Biostatistics & Safety Monitoring
Patient & Site Recruitment
Technology Transfer
Others
Indication Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
CNS Disorders
Infectious Diseases
Immunological Disorders
Cardiovascular Diseases
Respiratory Diseases
Diabetes
Ophthalmology
Pain Management
Others
Modality Outlook (Revenue, USD Million, 2021 - 2033)
Cell-Based Therapies
Gene Therapies
Gene-Modified Cell Therapies
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Norway
- Sweden
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Value chain based analysis (Model 2)
- 1.7.3. Multivariate Analysis (Model 3)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Cell & Gene Therapy Contract Research Organizations Market: Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Cell & Gene Therapy Contract Research Organizations Market Dynamics
- 3.2.1. Market Driver Impact Analysis
- 3.2.2. Market Restraint Analysis
3.3. Technological Landscape
3.4. Pricing Model Analysis
3.5. Cell & Gene Therapy Contract Research Organizations Market: Analysis Tools
- 3.5.1. Porter's Five Forces Analysis
- 3.5.2. PESTEL Analysis

Chapter 4. Cell & Gene Therapy Contract Research Organizations Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Cell & Gene Therapy Contract Research Organizations Market Type Movement Analysis
4.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Drug Discovery
- 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD million)
- 4.4.2. Target Validation
  - 4.4.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Lead Identification
  - 4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Lead Optimization
  - 4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Preclinical
- 4.5.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Clinical
- 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Phase I
  - 4.6.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Phase II
  - 4.6.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.4. Phase III
  - 4.6.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.5. Phase IV
  - 4.6.5.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cell & Gene Therapy Contract Research Organizations Market: Service Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Cell & Gene Therapy Contract Research Organizations Market Service Movement Analysis
5.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
5.4. Project & Clinical Trial Management
- 5.4.1. Project & Clinical Trial Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Regulatory Strategy
- 5.5.1. Regulatory Strategy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Data Management & Medical Writing
- 5.6.1. Data Management & Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Clinical Monitoring
- 5.7.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Quality Management / GMP Compliance
- 5.8.1. Quality Management / GMP Compliance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Biostatistics & Safety Monitoring
- 5.9.1. Biostatistics & Safety Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Patient & Site Recruitment
- 5.10.1. Patient & Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.11. Technology Transfer
- 5.11.1. Technology Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.12. Others
- 5.12.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cell & Gene Therapy Contract Research Organizations Market: Indication Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Cell & Gene Therapy Contract Research Organizations Market Indication Movement Analysis
6.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
6.4. Oncology
- 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. CNS Disorders
- 6.5.1. CNS Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Infectious Diseases
- 6.6.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Immunological Disorders
- 6.7.1. Immunological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Cardiovascular Diseases
- 6.8.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Respiratory Diseases
- 6.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10. Diabetes
- 6.10.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11. Ophthalmology
- 6.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12. Pain Management
- 6.12.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13. Others
- 6.13.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cell & Gene Therapy Contract Research Organizations Market: Modality Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Cell & Gene Therapy Contract Research Organizations Market Modality Movement Analysis
7.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
7.4. Cell-Based Therapies
- 7.4.1. Cell-Based Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Gene Therapies
- 7.5.1. Gene Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Gene-Modified Cell Therapies
- 7.6.1. Gene-Modified Cell Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cell & Gene Therapy Contract Research Organizations Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

8.1. Regional Market Dashboard
8.2. Global Regional Market Snapshot
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
- 8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
- 8.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7. Denmark
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.8. Sweden
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Competitive Scenario
  - 8.5.8.3. Regulatory Framework
  - 8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.9. Norway
  - 8.5.9.1. Key Country Dynamics
  - 8.5.9.2. Competitive Scenario
  - 8.5.9.3. Regulatory Framework
  - 8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.5. Australia
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Competitive Scenario
  - 8.6.6.3. Regulatory Framework
  - 8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key Country Dynamics
  - 8.6.7.2. Competitive Scenario
  - 8.6.7.3. Regulatory Framework
  - 8.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. MEA
- 8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Competitive Scenario
  - 8.8.2.3. Regulatory Framework
  - 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Competitive Scenario
  - 8.8.3.3. Regulatory Framework
  - 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Competitive Scenario
  - 8.8.4.3. Regulatory Framework
  - 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Competitive Scenario
  - 8.8.5.3. Regulatory Framework
  - 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Cell & Gene Therapy Contract Research Organizations Market Share Analysis, 2024
9.3. Company Profiles
- 9.3.1. Altasciences
  - 9.3.1.1. Company overview
  - 9.3.1.2. Financial performance
  - 9.3.1.3. Product benchmarking
  - 9.3.1.4. Strategic initiatives
- 9.3.2. Allucent
  - 9.3.2.1. Company overview
  - 9.3.2.2. Financial performance
  - 9.3.2.3. Product benchmarking
  - 9.3.2.4. Strategic initiatives
- 9.3.3. Labcorp
  - 9.3.3.1. Company overview
  - 9.3.3.2. Financial performance
  - 9.3.3.3. Product benchmarking
  - 9.3.3.4. Strategic initiatives
- 9.3.4. Linical
  - 9.3.4.1. Company overview
  - 9.3.4.2. Financial performance
  - 9.3.4.3. Product benchmarking
  - 9.3.4.4. Strategic initiatives
- 9.3.5. Medpace
  - 9.3.5.1. Company overview
  - 9.3.5.2. Financial performance
  - 9.3.5.3. Product benchmarking
  - 9.3.5.4. Strategic initiatives
- 9.3.6. Thermo Fisher Scientific Inc.
  - 9.3.6.1. Company overview
  - 9.3.6.2. Financial performance
  - 9.3.6.3. Product benchmarking
  - 9.3.6.4. Strategic initiatives
- 9.3.7. Precision Medicine Group, LLC.
  - 9.3.7.1. Company overview
  - 9.3.7.2. Financial performance
  - 9.3.7.3. Product benchmarking
  - 9.3.7.4. Strategic initiatives
- 9.3.8. QPS Holdings
  - 9.3.8.1. Company overview
  - 9.3.8.2. Financial performance
  - 9.3.8.3. Product benchmarking
  - 9.3.8.4. Strategic initiatives
- 9.3.9. Syneos Health
  - 9.3.9.1. Company overview
  - 9.3.9.2. Financial performance
  - 9.3.9.3. Product benchmarking
  - 9.3.9.4. Strategic initiatives
- 9.3.10. ICON plc
  - 9.3.10.1. Company overview
  - 9.3.10.2. Financial performance
  - 9.3.10.3. Product benchmarking
  - 9.3.10.4. Strategic initiatives

細胞・遺伝子治療開発製造受託機関の市場規模、シェア、動向分析レポート：タイプ別、サービス別、適応症別、モダリティ別、地域別、セグメント予測、2025～2033年

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type, By Service, By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章細胞・遺伝子治療開発製造受託機関市場：変数、動向、範囲

第4章細胞・遺伝子治療開発製造受託機関市場：タイプ別、推定・動向分析

第5章細胞・遺伝子治療開発製造受託機関市場：サービス別、推定・動向分析

第6章細胞・遺伝子治療開発製造受託機関市場：適応症別、推定・動向分析

第7章細胞・遺伝子治療開発製造受託機関市場：モダリティ別、推定・動向分析

第8章細胞・遺伝子治療開発製造受託機関市場：地域別、推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cell & Gene Therapy Contract Research Organizations Market: Variables, Trends, & Scope

Chapter 4. Cell & Gene Therapy Contract Research Organizations Market: Type Estimates & Trend Analysis

Chapter 5. Cell & Gene Therapy Contract Research Organizations Market: Service Estimates & Trend Analysis

Chapter 6. Cell & Gene Therapy Contract Research Organizations Market: Indication Estimates & Trend Analysis

Chapter 7. Cell & Gene Therapy Contract Research Organizations Market: Modality Estimates & Trend Analysis

Chapter 8. Cell & Gene Therapy Contract Research Organizations Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

Chapter 9. Competitive Landscape

細胞・遺伝子治療開発製造受託機関の市場規模、シェア、動向分析レポート：タイプ別、サービス別、適応症別、モダリティ別、地域別、セグメント予測、2025～2033年

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type, By Service, By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞・遺伝子治療開発製造受託機関市場：変数、動向、範囲

第4章 細胞・遺伝子治療開発製造受託機関市場：タイプ別、推定・動向分析

第5章 細胞・遺伝子治療開発製造受託機関市場：サービス別、推定・動向分析

第6章 細胞・遺伝子治療開発製造受託機関市場：適応症別、推定・動向分析

第7章 細胞・遺伝子治療開発製造受託機関市場：モダリティ別、推定・動向分析

第8章 細胞・遺伝子治療開発製造受託機関市場：地域別、推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cell & Gene Therapy Contract Research Organizations Market: Variables, Trends, & Scope

Chapter 4. Cell & Gene Therapy Contract Research Organizations Market: Type Estimates & Trend Analysis

Chapter 5. Cell & Gene Therapy Contract Research Organizations Market: Service Estimates & Trend Analysis

Chapter 6. Cell & Gene Therapy Contract Research Organizations Market: Indication Estimates & Trend Analysis

Chapter 7. Cell & Gene Therapy Contract Research Organizations Market: Modality Estimates & Trend Analysis

Chapter 8. Cell & Gene Therapy Contract Research Organizations Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章細胞・遺伝子治療開発製造受託機関市場：変数、動向、範囲

第4章細胞・遺伝子治療開発製造受託機関市場：タイプ別、推定・動向分析

第5章細胞・遺伝子治療開発製造受託機関市場：サービス別、推定・動向分析

第6章細胞・遺伝子治療開発製造受託機関市場：適応症別、推定・動向分析

第7章細胞・遺伝子治療開発製造受託機関市場：モダリティ別、推定・動向分析

第8章細胞・遺伝子治療開発製造受託機関市場：地域別、推定・動向分析

第9章競合情勢